CATO PHARMA ApS: Financial statements 2021
CVR: 33949596
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
CATO PHARMA ApS (CVR 33949596) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 0 and a net result of DKK -614 compared with DKK -352 the year before. Equity in the 2021 report amounted to DKK -280,940.
- Revenue
- DKK 0
- Gross Profit
- DKK 0
- Profit/Loss
- DKK -614
- Equity
- DKK -280,940
- Total Assets
- DKK 3,414
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | 0 | 0 | -614 | -281 t. | - |
| 2020 | 0 | 0 | -352 | -280 t. | - |
| 2019 | - | - | -588 | -280 t. | - |
| 2018 | - | - | -6 t. | -279 t. | - |
| 2017 | 0 | 0 | -539 | -274 t. | - |
Official annual report
Find more companies like CATO PHARMA ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
CATO PHARMA ApS has published its annual report for 2020. Revenue came to DKK 0, and the net result was DKK -352.
About CATO PHARMA ApS
CATO PHARMA ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 2011. The company has been dissolved. The company was registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. In 2024, the company reported a net result of DKK -1,668 compared with DKK -1,588 the year before. Equity in the 2024 report amounted to DKK -283,700.